# Data Storage Corp: financial statements, quarterly

DTST · Nasdaq · CIK 1419951 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dtst.md) · [Financials](/companies/dtst/financials.md) · [Filings](/companies/dtst/filings.md) · [Insiders](/companies/dtst/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dtst/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6.0](/filings/0001731122-24-001803.md) | [6.2 d](/filings/0001731122-25-000484.md) | [8.2](/filings/0001731122-25-000763.md) | [4.9](/filings/0001731122-25-001132.md) | [0.3](/filings/0001731122-25-001568.md) | [0.3 d](/filings/0001731122-26-000564.md) | [0.3](/filings/0001731122-26-000732.md) | [0.3](/filings/0001731122-26-001066.md) | [0.4](/filings/0001731122-25-001568.md) | [0.3 d](/filings/0001731122-26-000564.md) | [0.3](/filings/0001731122-26-000732.md) | [0.4](/filings/0001731122-26-001066.md) |
| Cost of revenue | $m | [3.7](/filings/0001731122-24-001803.md) | [3.6 d](/filings/0001731122-25-000484.md) | [5.3](/filings/0001731122-25-000763.md) | [2.5](/filings/0001731122-25-001132.md) | [0.2](/filings/0001731122-25-001568.md) | [0.2 d](/filings/0001731122-26-000564.md) | [0.2](/filings/0001731122-26-000732.md) | [0.2](/filings/0001731122-26-001066.md) | [0.2](/filings/0001731122-25-001568.md) | [0.2 d](/filings/0001731122-26-000564.md) | [0.2](/filings/0001731122-26-000732.md) | [0.2](/filings/0001731122-26-001066.md) |
| Gross profit | $m | [2.3](/filings/0001731122-24-001803.md) | [2.6 d](/filings/0001731122-25-000484.md) | [3.0](/filings/0001731122-25-000763.md) | [2.4](/filings/0001731122-25-001132.md) | [0.1](/filings/0001731122-25-001568.md) | [0.1 d](/filings/0001731122-26-000564.md) | [0.1](/filings/0001731122-26-000732.md) | [0.1](/filings/0001731122-26-001066.md) | [0.2](/filings/0001731122-25-001568.md) | [0.1 d](/filings/0001731122-26-000564.md) | [0.2](/filings/0001731122-26-000732.md) | [0.2](/filings/0001731122-26-001066.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [2.3](/filings/0001731122-24-001803.md) | [2.8 d](/filings/0001731122-25-000484.md) | [2.8](/filings/0001731122-25-000763.md) | [2.8](/filings/0001731122-25-001132.md) | [1.0](/filings/0001731122-25-001568.md) | [1.0 d](/filings/0001731122-26-000564.md) | [0.9](/filings/0001731122-26-000732.md) | [1.1](/filings/0001731122-26-001066.md) | [1.3](/filings/0001731122-25-001568.md) | [0.9 d](/filings/0001731122-26-000564.md) | [1.5](/filings/0001731122-26-000732.md) | [1.5](/filings/0001731122-26-001066.md) |
| Operating income | $m | [0.0](/filings/0001731122-24-001803.md) | [(0.2) d](/filings/0001731122-25-000484.md) | [0.2](/filings/0001731122-25-000763.md) | [(0.4)](/filings/0001731122-25-001132.md) | [(0.8)](/filings/0001731122-25-001568.md) | [(0.8) d](/filings/0001731122-26-000564.md) | [(0.7)](/filings/0001731122-26-000732.md) | [(1.0)](/filings/0001731122-26-001066.md) | [(1.1)](/filings/0001731122-25-001568.md) | [(0.8) d](/filings/0001731122-26-000564.md) | [(1.3)](/filings/0001731122-26-000732.md) | [(1.3)](/filings/0001731122-26-001066.md) |
| Interest expense | $m | [0.0](/filings/0001731122-24-001803.md) | [0.0 d](/filings/0001731122-25-000484.md) | [0.0](/filings/0001731122-25-000763.md) | [0.0](/filings/0001731122-25-001132.md) | [0.0](/filings/0001731122-24-001803.md) | [0.1 d](/filings/0001731122-25-000484.md) | [0.0](/filings/0001731122-25-000763.md) | [0.0](/filings/0001731122-25-001132.md) | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.0](/filings/0001731122-24-001803.md) | not reported | [0.0](/filings/0001731122-24-000815.md) | [0.0](/filings/0001731122-24-001251.md) | [0.0](/filings/0001731122-24-001803.md) | [(0.0) d](/filings/0001731122-26-000564.md) | not reported | not reported | [(1.0)](/filings/0001731122-25-001568.md) | [2.9 d](/filings/0001731122-26-000564.md) | [(0.3)](/filings/0001731122-26-000732.md) | [(0.1)](/filings/0001731122-26-001066.md) |
| Net income | $m | [0.2](/filings/0001731122-24-001803.md) | [(0.1) d](/filings/0001731122-25-000484.md) | [0.4](/filings/0001731122-25-000763.md) | [(0.2)](/filings/0001731122-25-001132.md) | [0.1](/filings/0001731122-25-001568.md) | [0.3 d](/filings/0001731122-25-000484.md) | [0.0](/filings/0001731122-26-000732.md) | [(0.7)](/filings/0001731122-26-001066.md) | [16.8](/filings/0001731122-25-001568.md) | [3.1 d](/filings/0001731122-26-000564.md) | [(0.6)](/filings/0001731122-26-000732.md) | [(1.2)](/filings/0001731122-26-001066.md) |
| Diluted EPS | $ per share | [0.02](/filings/0001731122-24-001803.md) | not reported | [0.05](/filings/0001731122-25-000763.md) | [(0.04)](/filings/0001731122-25-001132.md) | [0.02](/filings/0001731122-25-001568.md) | not reported | [0.00](/filings/0001731122-26-000732.md) | [(0.10)](/filings/0001731122-26-001066.md) | [2.20](/filings/0001731122-25-001568.md) | not reported | [(0.20)](/filings/0001731122-26-000732.md) | [(0.55)](/filings/0001731122-26-001066.md) |
| Basic EPS | $ per share | [0.03](/filings/0001731122-24-001803.md) | not reported | [0.05](/filings/0001731122-25-000763.md) | [(0.04)](/filings/0001731122-25-001132.md) | [0.02](/filings/0001731122-25-001568.md) | not reported | [0.00](/filings/0001731122-26-000732.md) | [(0.10)](/filings/0001731122-26-001066.md) | [2.30](/filings/0001731122-25-001568.md) | not reported | [(0.20)](/filings/0001731122-26-000732.md) | [(0.55)](/filings/0001731122-26-001066.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating, us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.0](/filings/0001731122-23-002107.md) | [1.4](/filings/0001731122-25-000484.md) | [0.6](/filings/0001731122-24-000815.md) | [0.8](/filings/0001731122-24-001251.md) | [0.5](/filings/0001731122-24-001803.md) | [1.1](/filings/0001731122-26-000564.md) | [0.7](/filings/0001731122-25-000763.md) | [0.6](/filings/0001731122-25-001132.md) | [0.3](/filings/0001731122-25-001568.md) | [2.0](/filings/0001731122-26-001066.md) | [0.1](/filings/0001731122-26-000732.md) | [0.3](/filings/0001731122-26-001066.md) |
| Current assets | $m | [14.7](/filings/0001731122-23-002107.md) | [14.5](/filings/0001731122-25-000484.md) | [17.0](/filings/0001731122-24-000815.md) | [14.7](/filings/0001731122-24-001251.md) | [14.6](/filings/0001731122-24-001803.md) | [15.4](/filings/0001731122-26-000564.md) | [17.4](/filings/0001731122-25-000763.md) | [14.8](/filings/0001731122-25-001132.md) | [47.5](/filings/0001731122-25-001568.md) | [42.6](/filings/0001731122-26-001066.md) | [11.6](/filings/0001731122-26-000732.md) | [11.0](/filings/0001731122-26-001066.md) |
| Total assets | $m | [23.6](/filings/0001731122-23-002107.md) | [23.3](/filings/0001731122-25-000484.md) | [25.8](/filings/0001731122-24-000815.md) | [24.3](/filings/0001731122-24-001251.md) | [24.2](/filings/0001731122-24-001803.md) | [25.3](/filings/0001731122-26-000564.md) | [26.9](/filings/0001731122-25-000763.md) | [24.4](/filings/0001731122-25-001132.md) | [47.7](/filings/0001731122-25-001568.md) | [43.0](/filings/0001731122-26-001066.md) | [11.8](/filings/0001731122-26-000732.md) | [11.1](/filings/0001731122-26-001066.md) |
| Current liabilities | $m | [3.8](/filings/0001731122-23-002107.md) | [3.5](/filings/0001731122-25-000484.md) | [5.6](/filings/0001731122-24-000815.md) | [3.5](/filings/0001731122-24-001251.md) | [3.0](/filings/0001731122-24-001803.md) | [3.5](/filings/0001731122-26-000564.md) | [4.9](/filings/0001731122-25-000763.md) | [2.7](/filings/0001731122-25-001132.md) | [8.4](/filings/0001731122-25-001568.md) | [2.0](/filings/0001731122-26-000564.md) | not reported | not reported |
| Total liabilities | $m | [3.9](/filings/0001731122-23-002107.md) | [3.5](/filings/0001731122-25-000484.md) | [5.6](/filings/0001731122-24-000815.md) | [4.0](/filings/0001731122-24-001251.md) | [3.6](/filings/0001731122-24-001803.md) | [4.1](/filings/0001731122-26-000564.md) | [5.5](/filings/0001731122-25-000763.md) | [3.2](/filings/0001731122-25-001132.md) | [8.4](/filings/0001731122-25-001568.md) | [2.3](/filings/0001731122-26-001066.md) | [1.1](/filings/0001731122-26-000732.md) | [1.0](/filings/0001731122-26-001066.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [19.9](/filings/0001731122-23-002107.md) | [20.0](/filings/0001731122-25-000484.md) | [20.5](/filings/0001731122-24-000815.md) | [20.6](/filings/0001731122-24-001251.md) | [20.9](/filings/0001731122-24-001803.md) | [21.4](/filings/0001731122-26-000564.md) | [21.7](/filings/0001731122-25-000763.md) | [21.5](/filings/0001731122-25-001132.md) | [39.5](/filings/0001731122-25-001568.md) | [40.9](/filings/0001731122-26-001066.md) | [10.9](/filings/0001731122-26-000732.md) | [10.3](/filings/0001731122-26-001066.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [1,082 d](/filings/0001731122-24-001803.md) | [1,712 d](/filings/0001731122-25-000484.md) | [(319)](/filings/0001731122-25-000763.md) | [673 d](/filings/0001731122-25-001132.md) | [198 d](/filings/0001731122-25-001568.md) | [1,187 d](/filings/0001731122-26-000564.md) | [(1,100)](/filings/0001731122-26-000732.md) | [372 d](/filings/0001731122-26-001066.md) | [172 d](/filings/0001731122-25-001568.md) | [(2,607) d](/filings/0001731122-26-000564.md) | [(1,778)](/filings/0001731122-26-000732.md) | [(867) d](/filings/0001731122-26-001066.md) |
| Capital expenditure | $k | [81.3 d](/filings/0001731122-24-001803.md) | [298 d](/filings/0001731122-25-000484.md) | [359](/filings/0001731122-25-000763.md) | [544 d](/filings/0001731122-25-001132.md) | [(900) d](/filings/0001731122-25-001568.md) | [0.0 d](/filings/0001731122-26-000564.md) | [1.2](/filings/0001731122-26-000732.md) | [0.0 d](/filings/0001731122-26-001066.md) | [(1.0) d](/filings/0001731122-25-001568.md) | [15.9 d](/filings/0001731122-26-000564.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [6,822](/filings/0001731122-23-002107.md) | [6,954](/filings/0001731122-24-000815.md) | [7,022](/filings/0001731122-24-001251.md) | [7,246](/filings/0001731122-24-001803.md) | [7,259](/filings/0001731122-25-000763.md) | [6,973](/filings/0001731122-25-001132.md) | [7,406](/filings/0001731122-25-001568.md) | [7,078](/filings/0001731122-26-000732.md) | [7,155](/filings/0001731122-26-001066.md) | [7,614](/filings/0001731122-25-001568.md) | [3,105](/filings/0001731122-26-000732.md) | [2,244](/filings/0001731122-26-001066.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 2,337,738 at 2026-08-13, from the cover of the [10-Q filed 2026-08-14](/filings/0001731122-26-001066.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.